HPV and Head & Neck Cancer Symposium, 17 May, 2013
Program Schedule

HPV and Head & Neck Cancer Symposium  

Aula Maxima, NUI Galway


Conference Programme


Friday, May 17th, 2013

8.30 – 9.10 Registration & Coffee

9.10 – 9.30 Welcoming addresses by various dignitaries and symposium organizers

Prof. Lokesh Joshi, Vice-President for Research NUIG

Prof. Ivan Keogh, Director of Academic Department of Otolargyngology, NUIG

First Session (Moderators: Prof. Gene Connolly, Dr. Mary Casey & Mr. Tony O'Connor)

9.30 – 9.50 Epidemiology
 – Dr. Linda Sharp (National Cancer Registry Ireland) 
Latest Head and Neck Cancer statistics and overview of HPV research in Ireland

9:50 – 10:10 Epidemiology – Dr. Michael O’Rorke (Queens University, Belfast) 
The increasing incidence of HPV-related Head and Neck Cancer and survival rates

10.10 – 10.30 Pathology – Prof. John O’Leary (Trinity College Dublin) 
HPV under the microscope. The difference with head and neck cancer

10.30 - 11.00 Detection methods – Prof. William Westra (Johns Hopkins, Baltimore)
The latest developments in detecting HPV-positive head and neck cancer

11.00 – 11.15 Coffee Break

Second Session (Moderators: Mr. John Lang, Ms. Orla Young & Prof. Ivan Keogh)

11.15–11.40 Clinical Management – Ms. Helena Rowley (Mater Hospital, Dublin) 
HPV and the diagnosis and treatment of Head and Neck Cancer… the Irish perspective

11.40–12.10 Clinical Management - Dr. Sara Pai (Johns Hopkins, Baltimore)
Work-up, surgery and management of a HPV-positive head and neck cancer patients at Johns Hopkins

12.10–12.35 Clinical Management - Dr. Mererid Evans (University of Cardiff) 
Chemotherapy for HPV-positive oropharyngeal squamous cell carcinomas - unanswered questions and controversies

12.35–1.00 Clinical Management - Prof. Terry Jones (University of Liverpool) 
The contemporary management of HPV-positive oropharyngeal squamous cell carcinomas - Where are we going?

1.00–2.00 Lunch

2.00–2.30 Discussion of case study - Mr. Paul O’Neill (Mater Hospital, Dublin)
Discussion with expert panel (Ms. Rowley, Dr. Pai, Dr. Evans, Prof. Jones) about treatment options and management strategies

Third Session (Moderators: Dr. Diarmuid O’Donovan, NUIG & Dr. Cara Usher National Centre for Pharmacoeconomics)

2.30–2.50 Health Economics - Prof. Kevin Frick (Johns Hopkins School of Public Health)
Economic Impact and burden of HPV-related Head and Neck Cancer

2.50 – 3.05 Infectious Disease Modelling – Dr. Deidre Hollingsworth (University of Warwick)
Considerations of infectious disease modelling

3.05 – 3.30 Economic Modelling - Dr. Ruth Chapman (United BioSource, London)
Cost-effectiveness of HPV vaccination in the HPV-Head and neck cancer era

3.30 – 4.00 Public Policy Perspective - Dr. Brenda Corcoran (Health Service Executive, National Immunization Office)
Human Papillomavirus Vaccination - The past, the present and the future


4.00 – 4.15 Concluding remarks and coffee